<DOC>
	<DOCNO>NCT01149499</DOCNO>
	<brief_summary>The objective study compare rate extent absorption valacyclovir 1000 mg tablet ( test ) versus Valtrex ( reference ) , administer 1 x 1000 mg tablet fast condition .</brief_summary>
	<brief_title>Valacyclovir 1000 mg Tablet Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion Criteria Male female , nonsmoker , 18 year age old . Capable consent BMI great equal 19.0 less equal 30.0 kg/m2 Exclusion Criteria Subjects follow applies exclude study : Clinically significant illness surgery within 4 week administration study medication . Any clinically significant abnormality find medical screening . Any reason , opinion medical subinvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Positive test hepatitis B , hepatitis C HIV screen . ECG abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 90 140 mmHg , diastolic blood pressure low 50 90 mmHg ; heart rate less 50 100 bpm ) screening . History significant alcohol drug abuse within one year prior screen visit Regular use alcohol within six month prior screen visit ( fourteen unit alcohol per week [ 1 Unit = 150 mL wine 360 mL beer 45 mL alcohol 40 % alcohol ] ) positive urine drug screen screen . Use soft drug ( marijuana ) within 3 month screen visit hard drug ( cocaine , phencyclidine ( PCP ) crack ) within 1 year prior screen visit positive urine drug screen screen . History allergic reaction heparin , valacyclovir , acyclovir , relate drug . Use drug know induce inhibit hepatic drug metabolism ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , omeprazole ; examples inhibitor : antidepressant ( SSRI ) , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) within 30 day prior administration study medication . Use investigational drug participation investigation study within 30 day prior administration study medication . Clinically significant history presence clinically significant gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) , unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease , condition know interfere absorption , distribution , metabolism excretion drug . Any clinically significant history presence clinically significant neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric metabolic disease . Use prescription medication within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption . Difficulty swallow study medication . Use tobacco product 90 day precede drug administration . Any food allergy , intolerance , restriction special diet , opinion medical subinvestigator , could contraindicate subject participation study . A depot injection implant drug within 3 month prior administration study medication . Donation plasma ( 500 mL ) within 30 day prior drug administration . Donation loss whole blood ( exclude volume blood drawn screening procedure study ) prior administration study medication follow : 50 mL 300 mL whole blood within 30 day , 301 mL 500 mL whole blood within 45 day , 500 mL whole blood within 56 day prior drug administration . Intolerance venipuncture . Clinically significant history renal , hepatic cardiovascular disease , tuberculosis , epilepsy , asthma , diabetes , psychosis glaucoma eligible study . Unable understand unwilling sign Informed Consent Form . Breastfeeding . Positive serum pregnancy test screening . Female subject childbearing potential unprotected sexual intercourse nonsterile male partner ( i.e . male sterilized vasectomy least 6 month ) within 14 day prior study drug administration . Acceptable method contraception : Intrauterine contraceptive device ( place least 4 week prior study drug administration ) , Condom diaphragm + spermicide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>